Home › Funds › EMERALD ADVISERS, LLC › TMDX
EMERALD ADVISERS, LLC position in TMDX
TRANSMEDICS GROUP INC · Health Care
EMERALD ADVISERS, LLC reported holding 493,026 shares of TMDX (TRANSMEDICS GROUP INC) in its Q3 2026 13F filing — a position valued at US$41.1M, representing 1.13% of its reported portfolio and ranking #28 among its reported holdings. EMERALD ADVISERS, LLC has disclosed TMDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EMERALD ADVISERS, LLC's TMDX position evolved
EMERALD ADVISERS, LLC first disclosed a stake in TMDX in Q3 2023 at 442,546 shares (US$24.2M). The position peaked in Q2 2025 at 439,329 shares, worth US$58.9M. Across 13 filings, EMERALD ADVISERS, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 493,026 shares valued at US$41.1M — an increase of 2,535 shares quarter over quarter.. Notable position changes include a 53% trim in Q3 2024 (shares fell 60% over the following quarter), a 146% increase in Q4 2024 (shares rose 8% over the following quarter), a 43% increase in Q2 2026 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 442.55K | $24.23M | New |
| Q4 2023 | 516.35K | $40.76M | Add |
| Q1 2024 | 523.42K | $38.70M | Add |
| Q2 2024 | 323.35K | $48.70M | Reduce |
| Q3 2024 | 150.91K | $23.69M | Reduce |
| Q4 2024 | 371.71K | $23.18M | Add |
| Q1 2025 | 454.79K | $30.60M | Add |
| Q2 2025 | 439.33K | $58.87M | Reduce |
| Q3 2025 | 387.59K | $43.49M | Reduce |
| Q4 2025 | 351.35K | $42.74M | Reduce |
| Q1 2026 | 342.79K | $34.08M | Reduce |
| Q2 2026 | 490.49K | $32.58M | Add |
| Q3 2026 | 493.03K | $41.14M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TMDX and 13F data
TMDX (TRANSMEDICS GROUP INC) is a Health Care company. 22 other funds we track also report a position in TMDX — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$64.8M), DeepCurrents Investment Group LLC (US$58.8M), BRAIDWELL LP (US$40.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TMDX
- TENOR CAPITAL MANAGEMENT Co., L.P. 59.56M sh · $64.77M · Q2 2026
- DeepCurrents Investment Group LLC 54.17M sh · $58.84M · Q2 2026
- BRAIDWELL LP 609.72K sh · $40.50M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 30.00M sh · $32.55M · Q2 2026
More on EMERALD ADVISERS, LLC
FAQ
How long has EMERALD ADVISERS, LLC held TMDX?
EMERALD ADVISERS, LLC has disclosed TMDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EMERALD ADVISERS, LLC's current position in TMDX?
As of Q3 2026, EMERALD ADVISERS, LLC holds 493.03K shares of TMDX (TRANSMEDICS GROUP INC), valued at $41.14M, representing 1.13% of its reported portfolio and ranking #28.
Has EMERALD ADVISERS, LLC been buying or selling TMDX?
In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC increased its position in TMDX. The position peaked in Q2 2025 at 439.33K shares.
Which other funds hold TMDX?
Other major institutional holders of TMDX include TENOR CAPITAL MANAGEMENT Co., L.P., DeepCurrents Investment Group LLC, BRAIDWELL LP, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.